Mordor Intelligence released its 2018 list of the companies with the highest influence on the global malaria diagnostics market.
According to the report, here are a few top global players:
Abbott is one of the major well-established companies for diagnostics products and tests, which are manufactured marketed and sold worldwide, including a broad line of products with applications in core laboratory systems, molecular diagnostics, point-of-care systems, rapid diagnostics systems. With the acquisition of Alere and its effectiveness as a subsidiary from January 2018, the company is expected to witness a strong and sustained growth in rapid diagnostics, including benchtop systems and rapid tests in areas of infectious diseases, including malaria, with a continued market penetration in the United States and China.
2. BioMérieux SA
BioMérieux SA is one of the global leaders in pioneering diagnostics for over 50 years, with its presence in over 150 countries and a broad network of distributors. Its immunoassay segment accounted for an increasing share of sales and revenue generation over the past two years. The company is actively involved in the public-private collaborations in the European Union. For instance, in France, it assists in monitoring artemisinin resistance and conducts training campaigns for the treatment of epidemic fever in African countries like Guinea, which is one of the strategies to capture market share in developing countries.
3. Bio-Rad Laboratories Inc.
Bio-Rad Laboratories has a stronghold in clinical diagnostics industry and is garnering demand for its broad range of in-vitro diagnostic tests products, with the United States accounting for a major share of its market, along with a rising demand in the developing countries. The major boost for the company in the malaria diagnostics domain is its significant investments in the R&D of in-vitro diagnostics, with over 3,000 different products that cover over 300 clinical diagnostic tests, offered to a wide range of end users, including laboratories, government agencies, hospitals, and pharmaceutical, biotechnology, and chemical companies.
4. Novartis AG
A continued investment in malaria initiatives, rapid diagnostic tests, and therapeutics has helped Novartis to carve a unique position for itself in the market. During the forecast period, the company is expected to work with Medicines for Malaria Venture, for conducting clinical trials in emerging economies and creating awareness to eliminate the infectious diseases. The company has made a significant impact since 2001, to provide treatments to patients in malaria-endemic countries. With its broad range of products in the pipeline, the company is expected to be one of the dominating players in the malaria diagnostics market.
Some of the other key players mentioned in the report are:
- Access Bio Inc.
- Danaher (Beckman Coulter)
- Premier Medical Corporation Pvt Ltd
- Siemens Healthineers
- Thermo Fisher Scientific
About the Malaria Diagnostics Market
The Mordor Intelligence report indicates that the global malaria diagnostics market is poised to register a CAGR of about 4.5% over the forecast period of 2018-2023, with an upsurge in the demand for technological advancements and diagnostic tools.
Mordor Intelligence is a market intelligence and advisory firm operating in 14 industry segments, serving over 600 clients worldwide.